Hydrogen and health / Research review
Hydrogen and diseases of the muscles and mitochondria: myopathies, dystrophy, myositis
Mitochondria are the main source of free radicals in the cell, which is why hydrogen has been tested in diseases in which they work faultily. In a Japanese study in people with mitochondrial myopathy, the authors observed a lower blood lactate level in the hydrogen water group, and in the open-label part a better lactate-to-pyruvate ratio, an index of mitochondrial function.
Covers
Studies
Human studies: 2 studies in the cards below, including 1 randomised.
How hydrogen was given
Hydrogen water.
On this page
Mitochondrial diseases: key findings from the studies
- Mitochondrial myopathy: a fall in blood lactate in the double-blind part.
- Open-label part (14 people, 12 weeks): a better lactate-to-pyruvate ratio, an index of mitochondrial function.
- Apart from one case of hypoglycaemia in a person on insulin, no adverse events were recorded.
Hydrogen and mitochondria: why muscle diseases are studied
Mitochondria produce the cell's energy and are the main source of reactive oxygen species. Hydrogen reacts selectively with the most reactive one, the hydroxyl radical. Hence the supposition that it may matter where mitochondria work faultily. In people with fatty liver, the efficiency of mitochondria in blood platelets improved after 8 weeks of drinking hydrogen water1.
Hydrogen water in mitochondrial myopathy: the 2011 study
The Japanese team carried out two parts2. In the open-label part, 14 people with mitochondrial myopathy, progressive muscular dystrophy, or polymyositis or dermatomyositis drank a litre of hydrogen water a day for 12 weeks. In the second, double-blind part, 12 people with mitochondrial myopathy and 10 with dermatomyositis drank half a litre a day for 8 weeks, alternating with placebo.
In the open-label part the lactate-to-pyruvate ratio, an index of mitochondrial function, improved. In the placebo-controlled part, lactate fell significantly in mitochondrial myopathy.
One person with MELAS syndrome who was on insulin had episodes of hypoglycaemia, which resolved once the insulin dose was reduced. The authors recorded no other adverse events.
Hydrogen and mitochondrial diseases: directions for further research
The authors concluded that hydrogen water had a favourable effect on mitochondrial function in mitochondrial myopathy and on inflammatory processes in polymyositis and dermatomyositis. They also pointed to a possible dose-dependent effect of hydrogen.
Hydrogen and mitochondrial diseases: the studies we refer to
Click an entry to see who took part in the study, how hydrogen was given and what the result was.
What the studies say
Selected scientific publications on molecular hydrogen in humans: a description of each study, its results and a link to the source.
1Platelet bioenergetics in fatty liver
Hydrogen watercontrolled studyn = 302023
Platelet bioenergetics in fatty liver
- Participants
- 17 H2, 13 placebo; plus 15 healthy reference people
- Protocol
- 3×330 ml/day, H2 >4 mg/l for 8 weeks
- Result
- After hydrogen, CoQ10 in platelets rose, TBARS fell and the efficiency of oxidative phosphorylation improved.
- Study context
- Placebo-controlled study. Participants: 30.
Sumbalová Z i wsp.. The Effect of Adjuvant Therapy with Molecular Hydrogen on Endogenous Coenzyme Q10 Levels and Platelet Mitochondrial Bioenergetics in Patients with Non-Alcoholic Fatty Liver Disease. International journal of molecular sciences 24(15): 12477. 2023. PubMed 37569850 · DOI · Full text
2Mitochondrial and inflammatory myopathies
Hydrogen waterrandomised trialn = 362011
Mitochondrial and inflammatory myopathies
- Participants
- Open-label part: 14 people (5 with mitochondrial myopathy, 5 with progressive muscular dystrophy, 4 with polymyositis or dermatomyositis). Crossover part: 12 people with mitochondrial myopathy and 10 with dermatomyositis; Japan
- Protocol
- Open-label part: 1.0 l of hydrogen water a day for 12 weeks. Crossover part: 0.5 l a day for 8 weeks or placebo, with a 4-week break
- Result
- Open-label part: a favourable change in the lactate-to-pyruvate ratio in mitochondrial myopathy and dystrophy, and in the MMP-3 level in myositis. Placebo-controlled part: a significant fall in lactate in mitochondrial myopathy.
- Study context
- Open-label study and crossover RCT, double-blind. Participants: 36.
Ito M i wsp.. Open-label trial and randomized, double-blind, placebo-controlled, crossover trial of hydrogen-enriched water for mitochondrial and inflammatory myopathies. Medical Gas Research 1: 24. 2011. PubMed 22146674 · DOI · Full text
Educational information, not medical advice. Full database of publications: Hydrogen Studies.
Mitochondrial diseases: topics in this area
Mitochondrial diseases and hydrogen: frequently asked questions
How was hydrogen given in the mitochondrial disease study?
In the open-label part, participants drank a litre of hydrogen water a day for 12 weeks. In the double-blind part they drank half a litre a day for 8 weeks, alternating with placebo.
What is the lactate-to-pyruvate ratio?
A blood test marker that shows how efficiently mitochondria produce energy. In the open-label part of the study it improved after 12 weeks of drinking hydrogen water.
Is it a medical device?
No. PRAGMA HYDROGEN is a device for wellness use. It does not replace a consultation with a doctor.
Is hydrogen inhalation safe?
In clinical trials, hydrogen inhalation was well tolerated. The generator has 8 safety features that stop it working if a fault occurs. Hydrogen is a flammable gas: do not smoke or use an open flame near the device. People with chronic conditions, pregnant women and children should consult a doctor before use.